TrueParallel, Author at AskBio - Page 4 of 5

AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Posted on September 2, 2020 (September 2, 2020) by TrueParallel in News
AskBio CSO Jude Samulski Receives 2020 Life Sciences Award from the Triangle Business Journal Posted on August 24, 2020 (August 24, 2020) by TrueParallel in News
AskBio Named to Inc. 5000 List of Fastest-Growing Private Companies Posted on August 12, 2020 (August 13, 2020) by TrueParallel in News
AskBio Appoints Michael Kranda as SVP Therapeutic Practice Leader for Its Growing CNS Portfolio Posted on August 6, 2020 (August 6, 2020) by TrueParallel in News
AskBio CSO Jude Samulski Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine Posted on August 3, 2020 (August 5, 2020) by TrueParallel in News
Libbie Mansell Joins AskBio as SVP Regulatory Affairs Posted on July 23, 2020 (July 23, 2020) by TrueParallel in News
AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System Posted on June 23, 2020 (August 6, 2020) by TrueParallel in News
AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome Posted on March 18, 2020 (August 6, 2020) by TrueParallel in News
Tim Kelly Joins AskBio as President of Manufacturing to Lead AAV Vector Production for Gene Therapy Posted on March 12, 2020 (March 12, 2020) by TrueParallel in News
CYTOO and AskBio Enter into Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder Posted on February 28, 2020 (February 28, 2020) by TrueParallel in News